-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 M+bvFj5RYa6qSdZ9Bg9rXCJYNQNZbmYACsIPZ/0O/qEf7MvldOxG/TIcUufHcxDN
 cmVHZE/wBWuQp0y9xczAgA==

<SEC-DOCUMENT>0000950144-04-012367.txt : 20041223
<SEC-HEADER>0000950144-04-012367.hdr.sgml : 20041223
<ACCEPTANCE-DATETIME>20041223145616
ACCESSION NUMBER:		0000950144-04-012367
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20041221
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20041223
DATE AS OF CHANGE:		20041223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PROXYMED INC /FT LAUDERDALE/
		CENTRAL INDEX KEY:			0000906337
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
		IRS NUMBER:				650202059
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22052
		FILM NUMBER:		041223919

	BUSINESS ADDRESS:	
		STREET 1:		2555 DAVIE ROAD
		STREET 2:		SUITE 110
		CITY:			FORT LAUDERDALE
		STATE:			FL
		ZIP:			33317-7424
		BUSINESS PHONE:		9544731001

	MAIL ADDRESS:	
		STREET 1:		2555 DAVIE ROAD
		STREET 2:		SUITE 110
		CITY:			FT LAUDERDALE
		STATE:			FL
		ZIP:			33317

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HMO PHARMACY INC
		DATE OF NAME CHANGE:	19930601
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>g92523e8vk.htm
<DESCRIPTION>PROXYMED INC.
<TEXT>
<HTML>
<HEAD>
<TITLE>ProxyMed Inc.</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<HR size="4" noshade color="#000000" style="margin-top: -5px">
<HR size="1" noshade color="#000000" style="margin-top: -10px">





<P align="center" style="font-size: 14pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<P align="center" style="font-size: 18pt"><B>FORM 8-K</B>


<P align="center" style="font-size: 10pt"><B>CURRENT REPORT<BR>
Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934</B>



<P align="center" style="font-size: 10pt">Date of Report (Date of earliest event reported): <B>December&nbsp;21, 2004</B>


<P align="center" style="font-size: 24pt"><B>PROXYMED, INC.<BR>
<HR align="center" size="1" noshade width="85%"></B>


<DIV align="center" style="font-size: 10pt">(Exact Name of Registrant as Specified in Charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="75%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>FLORIDA</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>000-22052</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>65-0202059</B></TD>
</TR>

<TR style="font-size: 1px">
    <TD align="center" valign="top"><HR size="1" noshade>&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><HR size="1" noshade>&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><HR size="1" noshade>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or Other<BR>
Jurisdiction of Incorporation)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Commission File Number)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(IRS Employer<BR>
Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><B>1854 Shackleford Court, Suite&nbsp;200<BR>
Norcross, Georgia 30093-2924</B><BR>
(Address of Principal Executive Offices)



<P align="center" style="font-size: 10pt"><B>(770)&nbsp;806-9918</B><BR>
(Registrant&#146;s telephone number, including area code)


<P align="left" style="font-size: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):



<P>
<TABLE width="100%" border="0" cellpadding="2" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="1%"></TD>
    <TD width="99%"></TD>
</TR>
<TR valign="top">
    <TD nowrap><FONT face="Wingdings">&#111;</FONT>&nbsp;</TD>
    <TD>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</TD>
</TR>
</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="2" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="1%"></TD>
    <TD width="99%"></TD>
</TR>
<TR valign="top">
    <TD nowrap><FONT face="Wingdings">&#111;</FONT>&nbsp;</TD>
    <TD>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD>
</TR>
</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="2" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="1%"></TD>
    <TD width="99%"></TD>
</TR>
<TR valign="top">
    <TD nowrap><FONT face="Wingdings">&#111;</FONT>&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))</TD>
</TR>
</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="2" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="1%"></TD>
    <TD width="99%"></TD>
</TR>
<TR valign="top">
    <TD nowrap><FONT face="Wingdings">&#111;</FONT>&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))</TD>
</TR>
</TABLE>


<P>
<HR size="1" noshade color="#000000" style="margin-top: -2px">
<HR size="4" noshade color="#000000" style="margin-top: -10px">






<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">







<P align="left" style="font-size: 10pt"><B>Item&nbsp;1.01. Entry into a Material Definitive Agreement.</B>


<P align="left" style="font-size: 10pt">On December&nbsp;21, 2004 ProxyMed entered into an Independent Contractor Agreement with Kevin M.
McNamara as an internal consultant. A copy of the Independent Contractor Agreement is being filed
as Exhibit&nbsp;99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item
1.01. Under the Independent Contractor Agreement, Mr.&nbsp;McNamara is entitled to receive a monthly
fee of $30,000 and options to purchase 75,000 shares of the Company&#146;s common stock at an exercise
price of $7.10 per share. Such options vest at the rate of 6,250 options each month until the
earlier of 12&nbsp;months or until the Independent Contractor Agreement is terminated.



<P align="left" style="font-size: 10pt"><B>Item&nbsp;8.01. Other Events.</B>


<P align="left" style="font-size: 10pt">Effective December&nbsp;21, 2004, Michael A. Hoover, CEO of the Company, resigned as Chairman and a member of the
Board of Directors, and Kevin M. McNamara, the former Chairperson of the Company&#146;s Audit Committee,
became Chairman of the Board of ProxyMed, Inc. Mr.&nbsp;Hoover will continue as the Company&#146;s Chief Executive Officer. A copy of the Company&#146;s
Press Release regarding this appointment is being filed as Exhibit&nbsp;99.2 to this Current Report on
Form 8-K.


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="85%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit No.</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Description</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Independent Contractor Agreement between ProxyMed, Inc. and Kevin M. McNamara dated December
21, 2004.</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press Release dated December&nbsp;22, 2004.</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<P align="center" style="font-size: 10pt"><B>SIGNATURES</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><B>PROXYMED, INC.</B><BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Judson E. Schmid
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Judson E. Schmid&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">Dated: December 23, 2004&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">EVP, Chief Accounting Officer and Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><B>Exhibit&nbsp;Index</B>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="85%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit No.</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Description</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Independent Contractor Agreement between ProxyMed, Inc. and Kevin M. McNamara dated December
21, 2004.</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press Release dated December&nbsp;22, 2004.</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">4
</DIV>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>g92523exv99w1.htm
<DESCRIPTION>INDEPENDENT CONTRACTOR AGREEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE>Independent Contractor Agreement</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<P align="right" style="font-size: 10pt"><B>Exhibit&nbsp;99.1</B>



<P align="center" style="font-size: 10pt"><U>INDEPENDENT CONTRACTOR AGREEMENT</U>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Independent Contractor Agreement (&#147;Agreement&#148;) is entered into and effective as of the
21st day of December, 2004, between ProxyMed, Inc., 1854 Shackleford Ct., Ste. 200, Norcross, GA
30093 (the &#147;Company&#148;), and Kevin McNamara (&#147;Contractor&#148;), 5015 Fountainhead Drive, Brentwood TN
37027, with reference to the following facts:

<P align="left" style="font-size: 10pt">The Company is engaged in the business of providing connectivity, medical cost containment
services, business process outsourcing solutions and related value-added products to physicians,
payers, pharmacies, medical laboratories, and other healthcare providers and suppliers.


<P align="left" style="font-size: 10pt">The Company desires to engage the services of Contractor as a consultant to the Company and its
Chief Executive Officer, which services shall be in addition to the duties of Contractor in
connection with his chairing the activities of the Board of Directors.


<P align="left" style="font-size: 10pt">Contractor desires to perform services for the Company in this connection.



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, the parties agree:


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;SERVICES TO BE RENDERED.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contractor shall provide to the Company such services as are reasonably requested by the Board
of Directors and the Company&#146;s Chief Executive Officer to assist the Chief Executive Officer in the
management of the Company. Contractor shall work diligently and use his best efforts to perform
such job responsibilities, and will devote a minimum of three business days per week (including
travel) to such endeavors. Contractor also agrees to make himself available by telephone when
additional communication relating to the provision of his services to the Company may so require.
Contractor shall have absolute discretion in deciding how to perform any services the Company may
require, subject to the direction of the Board of Directors. At Contractor&#146;s request, the Company
agrees to furnish such advice, information, and full cooperation as Contractor may reasonably
require. Contractor shall at all times comply with all applicable laws, rules, regulations, and
orders of any applicable government authority, and the Company&#146;s ethics policies.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contractor understands and acknowledges that he will, in connection with the provision of his
services to the Company, frequently be required to advise and/or consult with Company counsel (both
in-house and/or outside) to assist Company counsel in providing legal advice/services to Company
management. Contractor and the Company acknowledge that such communications are necessary to allow
Company counsel to accomplish the purposes for which they have been, or will be, engaged. Moreover,
Contractor, while not an employee of the Company, will be acting as an agent of the Company in
making and receiving such communications. Contractor further understands and acknowledges that such
communications are strictly confidential, protected by the attorney-client privilege and/or
attorney work product doctrine, and are not to be disclosed to any third party without the express
written consent of the Company&#146;s General Counsel.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;TERM.


<P align="center" style="font-size: 10pt">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as provided in the second sentence of this paragraph, this Agreement shall be on a
month-to-month basis, and shall automatically renew unless either party gives thirty days written
notice of non-renewal to the other; provided, however, that neither party shall give notice of
non-renewal with respect to the first six months from the date of execution by both parties.
Notwithstanding the foregoing, (i)&nbsp;this Agreement may be terminated by the Company immediately upon
written notice to Contractor for any breach of this Agreement by Contractor and no unvested Options
as of such date shall vest upon such termination or thereafter, and (ii)&nbsp;this Agreement may be
terminated by the Company prior to the end of such six month period for any other reason and the
Company shall not be obligated to make any further payments to Contractor under paragraph 3 of this
Agreement after the effective date of such termination provided that all of the Options (as defined
below) shall immediately vest upon the effective date of such termination.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;FEES &#038; EXPENSES.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contractor shall be paid at the rate of $30,000.00 per month. Contractor will also be granted
options (the &#147;Options&#148;) on 75,000 shares of the Company&#146;s common stock with an exercise price equal
to the closing price of the Company&#146;s stock on the 8<SUP>th</SUP> of December&nbsp;2004 and with a term
of 10&nbsp;years. The Options shall vest at a rate of 6,250 shares on each monthly anniversary of the
date of this Agreement so long as it continues in effect; provided that all of such Options shall
be become fully vested as provided in paragraph 2 of this Agreement or in the event of a change of
control (as such term will be defined in the agreement governing the Options) of the Company
occurring prior to the one year anniversary of the date of this Agreement regardless of whether
this Agreement has been terminated (other than as a result of a breach by Contractor). Contractor
shall also be reimbursed for all reasonable out-of-pocket expenses incurred in the performance of
its obligations hereunder, upon submission of reasonable documentation of such expenses.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;STATUS OF CONTRACTOR.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In performing under this Agreement, Contractor is and shall at all times be acting and
performing as an independent contractor to the Company, performing his duties in accordance with
his own judgment. The Company shall neither have nor exercise any control or direction over the
methods by which Contractor performs his work and function nor shall the Company have the right to
interfere with such freedom of action or prescribe rules or otherwise control or direct the manner
in which such services are performed, subject, in each case, to the reasonable oversight and
direction of the Board of Directors. The sole interest of the Company in the services performed by
Contractor is that such services be performed by Contractor in a legal, competent, efficient, and
satisfactory manner. Consistent with the foregoing, the Company shall not make any deduction with
respect to Contractor for any payroll taxes, contributions for unemployment or workers&#146;
compensation insurance, social security premiums, or other benefits which are customarily measured
by wages, salaries or other compensation paid to an employee. Contractor shall indemnify and hold
harmless the Company from and against any and all taxes, fees, or penalties assessed against the
Company as a result of the Company&#146;s failure to make such deductions. Nothing contained herein
shall cause the relationship between the parties to be that of employer and employee. Except to the
limited extent, if any, necessary to preserve the integrity of the attorney-client privilege
applicable to communications described in paragraph 1


<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<P align="left" style="font-size: 10pt">hereof, Contractor, acting in such capacity, shall not have the authority to obligate or bind
the Company to any contract, obligation, or undertaking whatsoever, and shall make no
representation, either oral or in writing, except those expressly set forth in materials provided
by the Company.



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;NONDISCLOSURE.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contractor acknowledges that the details of the Company&#146;s business are confidential.
Contractor agrees that he will not, directly or indirectly, use, disseminate or disclose any
confidential information (including, but not limited to, communications protected by the
attorney-client privilege and/or attorney work product doctrine) of the Company during or
subsequent to the term of this Agreement. During the term of this Agreement, Contractor shall use
the documents and materials provided by the Company only in connection with the performance of
duties required by the Company.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contractor further acknowledges that the securities laws of the United States and of the
separate states comprising the United States apply to the trading of the Company&#146;s stock, and that
these securities laws prohibit any person or entity which is aware of material, non-public
information about a publicly traded company from purchasing or selling securities of such
company, or from communicating such information to any other person under circumstances in which it
is reasonably foreseeable that such other person is likely to base a decision to purchase, retain
or sell such securities.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;TERMINATION.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event this Agreement is terminated, Contractor shall be paid a pro-rated amount
representing the monthly fee for the month in which such termination occurs.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;GENERAL PROVISIONS.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Arbitration.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as provided in Section&nbsp;7(k), any controversy between the parties arising out of or
relating to this Agreement, or involving the construction or application of any of the terms,
provisions, or conditions of the Agreement, shall, on the written request of either party served on
the other, be submitted to arbitration, and such arbitration shall comply with and be governed by
the provisions of the Federal Arbitration Act, 9 U.S.C. sections 1, <U>et</U> <U>seq</U>. The
decision of the arbitrator shall be final and conclusive upon both parties.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Further Documents.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each party shall execute and deliver all such further instruments, documents, and papers, and
shall perform any and all acts necessary to give full force and effect to all of the terms and
provisions of this Agreement.


<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">

<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Successors and Assigns.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except where expressly provided to the contrary, this Agreement, and all provisions hereof,
shall inure to the benefit of and be binding upon the parties hereto, their successors in interest,
assigns, administrators, executors, heirs and devisees.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Severability.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If any provision of this Agreement, as applied to any party or to any circumstance, shall be
held to be void, invalid or unenforceable, the same shall in no way affect any other provision of
this Agreement, the application of such provision in any other circumstance, or the validity or
enforceability of this Agreement.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Notices.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All notices or demands shall be in writing and shall be served personally, by telecopier, or
by express or certified mail at the addresses set forth above. Service shall be deemed conclusively
made at the time of service if personally served, at the time that the telecopied transmission is
successfully completed, twenty-four (24)&nbsp;hours after deposit thereof in the United States mail,
properly addressed and postage prepaid, return receipt requested, if served by express mail, and
five (5)&nbsp;days after deposit thereof in the United States mail, properly addressed and postage
prepaid, return receipt requested, if served by certified mail. Any party may, by virtue of written
notice in compliance with this paragraph, alter or change the address or the identity of the person
to whom any notice, or copy thereof, is to be sent.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Waiver.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A waiver by any party of any of the terms and conditions of this Agreement in any one instance
shall not be deemed or construed to be a waiver of such term or condition for the future, or of
any subsequent breach thereof Any party may waive any term, provision or condition included for the
benefit of such a party.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Construction.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Agreement shall be governed by and construed with the laws of the State of Georgia
applicable to contracts entered into therein. In all matters of interpretation, whenever necessary
to give effect to any provision of this Agreement, each gender shall include the other, the
singular shall include the plural, and the plural shall include the singular. The titles of the
paragraphs of this Agreement are for convenience only and shall not in any way affect the
interpretation of any provision or condition of this Agreement.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;Entire Understanding.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Agreement contains the entire understanding of the parties hereto relating to the subject
matter contained herein and supersedes all prior and collateral agreements, understandings,
statements, and negotiations of the parties. Each party acknowledges and agrees that no
representations, inducements, promises, or agreements, oral or


<P align="center" style="font-size: 10pt">4
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<P align="left" style="font-size: 10pt">written, with reference to the subject matter hereof have been made other than as expressly
set forth herein. This Agreement cannot be modified, changed, rescinded, or terminated orally.



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;Attorneys&#146; Fees.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event of any litigation or arbitration between the parties hereto respecting or arising
out of this Agreement, the prevailing party shall be entitled to recover reasonable attorneys&#146;
fees.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;Place of Litigation.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any litigation or arbitration between the parties shall occur exclusively in the County of
Gwinnett, Georgia.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;Counterparts.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Agreement may be executed in counterparts which, taken together, shall constitute the
whole of the agreement as between the parties.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;Invalid Until Executed.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No legal rights will accrue to either party unless or until this Agreement shall have been
fully executed.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above
written.


<P align="left" style="font-size: 10pt">PROXYMED, INC.



<P align="left" style="font-size: 10pt">By: /s/ David E. Oles
<HR align="left" size="1" noshade width="35%">



<DIV align="left" style="font-size: 10pt">Its: Secretary</DIV>


<P align="left" style="font-size: 10pt">/s/ Kevin M. McNamara
<HR align="left" size="1" noshade width="35%">



<DIV align="left" style="font-size: 10pt">Kevin McNamara</DIV>


<P align="center" style="font-size: 10pt">5
</DIV>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>g92523exv99w2.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<P align="right" style="font-size: 10pt"><B>Exhibit&nbsp;99.2</B>


<DIV align="left">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="75%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="45%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&#091;ProxyMed Logo&#093;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">For Immediate Release</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><U><B>Investor Relations:</B></U>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><U><B>Media Relations:</B></U></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Gregory J. Eisenhauer, CFA</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>Teresa Stubbs</B></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>EVP &#038; Chief Financial Officer</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>Senior Director of Marketing</B></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>770-806-4780</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>800-937-3865, ext. 287</B></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><U><B>geisenhauer@proxymed.com</B></U>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><U><B>tstubbs@proxymed.com</B></U></TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 12pt"><B>PROXYMED SEPARATES CHAIRMAN AND CHIEF EXECUTIVE OFFICER ROLE</B>


<DIV align="center" style="font-size: 10pt"><I>Kevin McNamara to become Chairman; Michael Hoover to continue as Chief Executive Officer</I></DIV>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ATLANTA, GA, December&nbsp;22, 2004 &#150; ProxyMed, Inc. (Nasdaq: PILL) (the &#147;Company&#148;), a leading
provider of healthcare transaction processing and medical cost containment services, announced
today that in keeping with good corporate governance practices it will separate the roles of the
Company&#146;s Chairman and Chief Executive Officer. Kevin McNamara, who previously served as the
Chairman of the Audit Committee of the Board, will serve as the new Chairman of the Board. Michael
Hoover will continue to serve as the Chief Executive Officer of the Company. In addition to serving
as the Chairman of the Board, Mr.&nbsp;McNamara has entered into a consulting arrangement with Company
reflecting his increased level of activity at the Company.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;The Board of Directors and I have determined that the separation of the offices of Chairman
and CEO can be a beneficial component of an effective corporate governance system,&#148; said Mr.
Hoover. Mr.&nbsp;Hoover noted that a number of Fortune 500 companies have taken similar action in the
recent past.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr.&nbsp;McNamara has been an influential member of ProxyMed&#146;s Board of Directors since joining in
September&nbsp;2002. Prior to today&#146;s appointment, Mr.&nbsp;McNamara served as head of the Company&#146;s Audit
Committee. &#147;I am very pleased to have Kevin expand his role from Board member to Chairman,&#148; said
Mike Hoover. &#147;His background in healthcare and EDI, and his financial expertise have already been
invaluable to the Company in his role as Audit Committee Chair. With his expanded role, we look
forward to his additional contributions.&#148;


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition to his role with ProxyMed, Mr.&nbsp;McNamara currently serves as Chief Financial
Officer of HCCA International, Inc., a healthcare management and recruitment company, and is a
Director for Comsys IT Partners, Inc. where he also serves as the Chair of the Audit Committee.
From November&nbsp;1999 until February&nbsp;2001, Mr.&nbsp;McNamara served as Chief Executive Officer and a
director of Private Business, Inc., a provider of electronic commerce solutions that help community
banks provide accounts receivable financing to their small business customers. From 1996 to 1999,
Mr.&nbsp;McNamara served as Senior Vice President and Chief Financial Officer of Envoy Corporation.
Before joining Envoy, he served as president of NaBanco Merchant Services Corporation, then


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<P align="left" style="font-size: 10pt">one of the world&#146;s largest merchant credit card processors. Mr.&nbsp;McNamara currently serves on
the Board of Directors of Luminex Corporation, a medical device company and several private
companies.



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board also appointed Thomas A. Hodapp to replace Mr.&nbsp;McNamara on the Audit Committee and
Mr.&nbsp;William H. Bennett, currently a member of the Audit Committee, has been appointed Chairman of
the Audit Committee.


<P align="left" style="font-size: 10pt"><U><B>About ProxyMed, Inc.</B></U>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ProxyMed provides connectivity, medical cost containment services, business process outsourcing
solutions and related value-added products to physicians, payers, pharmacies, medical laboratories,
and other healthcare providers and suppliers. ProxyMed&#146;s services support a broad range of both
financial and clinical transactions, and we are HIPAA certified through Edifecs. To facilitate
these services, ProxyMed operates Phoenix&#153;, our secure national electronic information platform,
which provides physicians and other primary care providers with direct connectivity to payers,
chain and independent pharmacies and clinical laboratories.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For more information, please visit the Company&#146;s website at <U>www.proxymed.com</U>.


<P align="left" style="font-size: 10pt"><U><B>Forward Looking Statement</B></U>


<P align="left" style="font-size: 8pt"><I>ProxyMed cautions that forward-looking statements contained in this document are based on current
plans and expectations, and that a number of factors could cause the actual results to differ
materially from such statements. Some of these factors are described in the Safe Harbor statement
below. Except for the historical information contained herein, the matters discussed in this
document may constitute forward-looking statements that involve risks and uncertainties that could
cause actual results to differ materially from those projected. In some cases, forward-looking
statements can be identified by terminology such as &#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;potential,&#148;
&#147;continue,&#148; &#147;expects,&#148; &#147;anticipates,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;believes,&#148; &#147;estimates,&#148; and similar
expressions. While these statements reflect our current judgment, they are subject to risks and
uncertainties. Actual results may differ significantly from projected results due to a number of
factors. For further cautions about the risks of investing in ProxyMed, we refer you to the
documents each company files from time to time with the Securities and Exchange Commission,
particularly the Company&#146;s Form 10-K for the year ended December&nbsp;31, 2003 and Form 10-Q for the
period ending September&nbsp;30, 2004. Although this release may remain available on the Company&#146;s
website or elsewhere, its continued availability does not indicate that the Company is reaffirming
or confirming any of the information contained herein.</I>



<P align="center" style="font-size: 10pt">###




<P align="center" style="font-size: 10pt">&nbsp;
</DIV>


</BODY>
</HTML>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
